IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 1 - 20 of 1128 stories.
October 2, 2014
Bayer, which has just closed the acquisition of Merck & Co.’s over-the-counter (OTC) business, today announced that it is issuing a jumbo bond in 144A/Reg S format with a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-launches-$7-billion-bond-to-finance-Merck-and-Co-OTC-acquisition_64223.html
October 1, 2014
Johnson & Johnson, the biggest maker of consumer health products, has announced a definitive agreement to acquire Alios BioPharma (South San Francisco, CA), a privately held...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-and-Johnson-to-acquire-Alios-BioPharma-for-$1-75-billion_64182.html
September 30, 2014
Pharmaceutical companies Strides Arcolab (Bangalore, India) and Shasun Pharmaceuticals (Chennai, India) have announced their plans to merge. The boards of directors of the two...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-manufacturer-Shasun-announces-merger-with-Strides-Arcolab_64146.html
September 30, 2014
Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) to health-care firm Consort...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Consort-Medical-to-acquire-Aesica-for-$372-million_64142.html
September 30, 2014
Consort Medical to acquire Aesica for $372 million Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-30-September-2014_64147.html
September 23, 2014
Merck KGaA to acquire Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) says it has entered into a definitive agreement to acquire Sigma-Aldrich (St. Louis) for $17...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-September-2014_63943.html
September 22, 2014
Merck KGaA (Darmstadt, Germany) says its biopharmaceutical division is well on track with implementing the group’s Fit for 2018 transformation and growth program. At an analysts'...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-steps-up-investment-in-biosimilar-activities_63913.html
September 17, 2014
Merck KGaA today declined to comment on a report in The Economic Times of India that it is close to signing a deal, worth $1.5 billion, with India’s pharma major Lupin (Mumbai)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lupin-to-manufacture-Merck-Serono-drugs-under-$1-5-billion-deal_63820.html
September 16, 2014
Merck Serono, the biopharmaceutical division of Merck KGaA, today confirmed that it is establishing a long-term strategic partnership with Lupin (Mumbai). Lupin will support Merck...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-Serono-confirms-pharma-alliance-with-Lupin-targeting-emerging-markets_63840.html
September 16, 2014
Seattle Genetics and Genmab enter into antibody-drug conjugate collaboration Biotechnology companies Seattle Genetics (Bothell, WA) and Genmab (Copenhagen) say that they have entered...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-16-September-2014_63843.html
September 9, 2014
Mercachem to acquire Synthon’s API operations at Prague Mercachem (Nijmegen, Netherlands) says that it has agreed to acquire pharmaceutical company Synthon’s (Nijmegen)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-9-September-2014_63674.html
September 9, 2014
Mercachem (Nijmegen, Netherlands) says that it has agreed to acquire pharmaceutical company Synthon’s (Nijmegen) Prague-based laboratory and pilot scale operations for the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mercachem-to-acquire-Synthons-API-operations-at-Prague_63673.html
September 2, 2014
Albemarle has completed the previously announced sale of its antioxidant, ibuprofen, and propofol businesses and related assets to SI Group (Schenectady, NY), Albemarle said today...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-completes-sale-of-antioxidant-business-to-SI-Group_63559.html
September 2, 2014
Amerigen Pharmaceuticals, Ningbo Menovo sign generics deal; Menovo to manufacture APIs Amerigen Pharmaceuticals (Lyndhurst, NJ) and Ningbo Menovo Pharmaceutical (Ningbo, China) have...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-2-September-2014_63556.html
August 28, 2014
Amerigen Pharmaceuticals (Lyndhurst, NJ) and Ningbo Menovo Pharmaceutical (Ningbo, China) have entered into a collaboration agreement for the development of generic pharmaceuticals...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Amerigen-Pharmaceuticals-Ningbo-Menovo-sign-generics-deal-Menovo-to-manufacture-APIs_63445.html
August 26, 2014
Siegfried reports a slight increase in profits Siegfried (Zofingen, Switzerland) reports a 1.6% rise in net profits for the first six months of 2014 compared with the year-ago period...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-26-August-2014_63389.html
August 25, 2014
Roche (Basel) said today that it has agreed to acquire InterMune (Brisbane, CA), a biotech company focused on R&D and commercializing therapies in pulmonology and orphan fibrotic...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Roche-to-buy-US-biotech-firm-InterMune-for-$8-3-billion_63366.html
August 22, 2014
Siegfried (Zofingen, Switzerland) reports a 1.6% rise in net profits for the first six months of 2014 compared with the year-ago period, to 18.8 million Swiss francs ($20.5 million)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Siegfried-reports-a-slight-increase-in-profits_63355.html
August 19, 2014
Perrigo's API segment reports fall in sales and operating profits The active pharmaceutical ingredient (API) business segment of Perrigo (Dublin) reports a 20.5% fall in sales in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-19-August-2014_63287.html
August 12, 2014
Galenica (Bern, Switzerland) said today that it is adapting a new management structure. The group will be headed by two CEOs, one in charge of Vifor Pharma, formerly the pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Swiss-health-care-group-Galenica-to-split-into-two-listed-companies_63125.html
Pages:  [1] 2 3 4 5 6 7 8 9 10 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa